Compound Detail
CHEMBL4650299
HEPARIN 💊 Approved Drug
Enter ChEMBL ID:
Free Research Context
This compound will appear in recent viewed items on the research home for this browser.
Research home
View demo workspace
💊 Approved Drug
No structure available
Basic Information
| ChEMBL ID | CHEMBL4650299 |
| Name | HEPARIN |
| Phase | Approved |
| Structure Type | NONE |
| Therapeutic | ✓ Yes |
0
Targets
0
Activities
0
Assay Types
0
PK Parameters
0
Publications
5
Known Names
20
Indications
1
Mechanisms
Drug Information
| Molecule Type | Oligosaccharide |
| First Approval | 2023 |
| Availability | Prescription |
| Chirality | Single Enantiomer |
Mechanism of Action
| Mechanism | Action Type | Target | Direct | Efficacy |
|---|---|---|---|---|
| Antithrombin-III activator | ACTIVATOR | Antithrombin-III | ✓ | ✓ |
Indications
Eye Diseases Thrombosis Thrombosis Varicose Veins Acute Coronary Syndrome Acute Lung Injury Angina, Stable Aortic Valve Stenosis Bacterial Infections Cardiovascular Diseases Colorectal Neoplasms Coronary Disease Diabetes Mellitus, Type 2 Fetal Growth Retardation Genital Neoplasms, Female Heart Diseases Hemorrhage Infections Myocardial Infarction Myocardial Infarction
ATC Classification
B01AB01
heparin
Level 1: BLOOD AND BLOOD FORMING ORGANS
Level 2: ANTITHROMBOTIC AGENTS
C05BA03
heparin
Level 1: CARDIOVASCULAR SYSTEM
Level 2: VASOPROTECTIVES
S01XA14
heparin
Level 1: SENSORY ORGANS
Level 2: OPHTHALMOLOGICALS
Data from ChEMBL 36 via Core Engine